Injectable drug products need to have an extreme and successful sterile fill to finish. How do you ensure your manufacturers obtain the highest level of operational and quality excellence? Manufacturing environments must be tightly controlled—especially due to the increase in demand of sterile injectables. Qualifying every part of the product leading up to the final…
Read more
Recall of Sodium Acetate Injection Due to the Presence of Particulate Matter
Fresenius Kabi is a global health care company that produces and specializes in medication and infusion/transfusion technology. Fresenius Kabi USA voluntarily recalled seven lots of Sodium Acetate Injection on Monday, March 7th. Various amounts of iron, sodium, silicon, chromium, aluminum and cellulose found in these injections led to seven lots being recalled. The presence of…
Read more
Serialization Challenges of Track & Trace in the Biopharma Industry
10% of drugs sold around the world are fake. Counterfeit medicines are the cause of on average 1 million deaths yearly. Increasing of online purchases and disrupted supply chains have intensified and made the risk of counterfeit medicines due to COVID-19. Drugs are “tracked” once after the product has left the manufacturer and landed where…
Read more
Sagent Pharmaceuticals, Inc. Issues Nationwide Recall
November 19, 2021, Sagent Pharma announces a voluntary nationwide recall of Levetiracetam Injection. Four lots of Levetiracetam was recalled due to the lack of a sterile product. Issues pertaining to container closure integrity was brought to attention when found in reserve sample vials. Sagent Pharmaceuticals did not follow USP suggested guidelines for container closure integrity—distributing…
Read more